3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pain, Postoperative
2
Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Sexual Dysfunction, Physiological
1
Pain
1
Ovarian Neoplasms
1
Mucositis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Chronic Pain
1
Anastomotic Leak
1
Agnosia
1
Acute Pain
1
Interventions
Fentanyl
3
Sodium Chloride
2
Pregabalin
2
Morphine
2
Mindfulness-Based Stress Reduction
2
Ketamine
2
Hypnosis
2
Dexmedetomidine
2
Bupivacaine
2
Anesthetics, Local
2
tianeptine
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Therapeutics
1
Telemedicine
1
Tea
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Ropivacaine
1
Plastic Surgery Procedures
1
Nerve Block
1
Mindfulness-Based Cognitive Therapy
1
Mindfulness
1
Methadone
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Exercise Therapy
1
Epinephrine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Chronic Pain
×
Anti-Inflammatory Agents, Non-Steroidal
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled